Combination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growth (2020)
Source: Gene Therapy. Unidades: ICB, FM
Subjects: BIOLOGIA CELULAR, NEOPLASIAS PROSTÁTICAS, QUIMIOTERAPIA, CÉLULAS CULTIVADAS DE TUMOR, LEUCOPENIA ANIMAL, CAMUNDONGOS, MODELOS ANIMAIS
ABNT
TAMURA, Rodrigo Esaki; LANA, Marlous Vinicius Gomes; STRAUSS, Eugenia Costanzi; STRAUSS, Bryan Eric. Combination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growth. Gene Therapy, London, 2020. Disponível em: < https://doi.org/10.1038/s41434-019-0071-x > DOI: 10.1038/s41434-019-0071-x.APA
Tamura, R. E., Lana, M. V. G., Strauss, E. C., & Strauss, B. E. (2020). Combination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growth. Gene Therapy. doi:10.1038/s41434-019-0071-xNLM
Tamura RE, Lana MVG, Strauss EC, Strauss BE. Combination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growth [Internet]. Gene Therapy. 2020 ;Available from: https://doi.org/10.1038/s41434-019-0071-xVancouver
Tamura RE, Lana MVG, Strauss EC, Strauss BE. Combination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growth [Internet]. Gene Therapy. 2020 ;Available from: https://doi.org/10.1038/s41434-019-0071-x